Trial
NCT03598777
Dysport in Vulvodynia Phase II Study
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Ipsen
Collaborators
—
Condition
Vulvodynia
Intervention
Botulinum toxin type A
Why stopped
lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-09